Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype |cirrhosis
Sentences 171
PubMedID- 24893685 Background: an association between transjugular intrahepatic porto-systemic shunt (tips) and the development of hepatocellular carcinoma in patients with cirrhosis has been suggested, but not confirmed.
PubMedID- 21881927 Of the remaining ten patients, four had hepatitis c-related cirrhosis (one also with hepatocellular carcinoma), three had alcoholic cirrhosis, two had primary biliary cirrhosis, and one had non-alcoholic, fatty liver disease-associated cirrhosis.
PubMedID- 23768738 Background: liver resection for hepatocellular carcinoma (hcc) combined with nash -related cirrhosis has become increasingly common.
PubMedID- 26166077 Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group).
PubMedID- 22056847 Hepatitis b virus (hbv) infection has a wide variety of clinical outcomes, it could be spontaneouly recovered and also could develop fulminant liver failure or cirrhosis with hepatocellular carcinoma.
PubMedID- 23146511 Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient.
PubMedID- 25785114 Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china.
PubMedID- 22483505 The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma.
PubMedID- 25465804 The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.
PubMedID- 25436303 As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure.
PubMedID- 24352343 There were 383 patients with cirrhosis associated with hepatocellular carcinoma (hcc).
PubMedID- 25473157 These include those with underlying cirrhosis, severe flares of chb, hepatocellular carcinoma (hcc), and for those undergoing liver transplantation.
PubMedID- 24932302 Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: a report of two cases.
PubMedID- 22778970 In the present systematic review, we explore the different aspects of the management of pvt in individuals with cirrhosis (excluding cases associated with hepatocellular carcinoma).
PubMedID- 20004441 Background: the choice between minor versus major resection or anatomic versus nonantatomic resection for small (<5 cm) solitary hepatocellular carcinoma (hcc) in patients with cirrhosis is controversial.
PubMedID- 24034029 Background: liver transplantation (olt) is the gold standard therapy for patients with cirrhosis complicated by hepatocellular carcinoma (hcc) within milan criteria (mc).
PubMedID- 22982095 Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
PubMedID- 24229043 A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction.
PubMedID- 22363353 Some individuals with persistent hcv infections develop liver cirrhosis, which can lead to hepatocellular carcinoma in some patients [1][2][3][4].
PubMedID- 24815863 Because cirrhosis underlies most cases of hepatocellular carcinoma (hcc) and advanced cirrhosis can, in fact, affect patients’ survival to a greater degree than the carcinoma itself (3,4), the ctp score has become the standard prognostic tool for predicting survival and for assessing hepatic reserve to guide initial or subsequent therapy decisions by predicting risk of liver failure and death after local and systemic therapies and for categorizing patients under hcc staging systems for trial entry (5).
PubMedID- 21896165 In 40-60% of hcv-infected individuals, chronic infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [3,4].

Page: 1 2 3 4